VRS
BIO icon

Virginia Retirement Systems’s Bio-Rad Laboratories Class A BIO Stock Holding History

Virginia Retirement Systems’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$415K Sell
1,370
-1,530
-53% -$477K ﹤0.01% 794
2025
Q3 		$813K Buy
2,900
+200
+7% +$54.4K 0.01% 644
2025
Q2 		$652K Buy
+2,700
New +$638K ﹤0.01% 696
2023
Q2 		– Sell
-10,857
Closed -$5.2M – 980
2023
Q1 		$5.2M Sell
10,857
-24,043
-69% -$11.3M 0.05% 237
2022
Q4 		$14.7M Buy
34,900
+4,600
+15% +$1.86M 0.15% 168
2022
Q3 		$12.6M Buy
+30,300
New +$15.1M 0.14% 170
2022
Q1 		$17.7M Buy
31,500
+17,600
+127% +$10.6M 0.17% 153
2021
Q4 		$10.5K Sell
13,900
-1,900
-12% -$1.42M 0.07% 223
2021
Q3 		$11.8M Sell
15,800
-100
-0.6% -$74.9K 0.12% 199
2021
Q2 		$10.2M Sell
15,900
-1,800
-10% -$1.1M 0.1% 221
2021
Q1 		$10.1M Buy
17,700
+1,600
+10% +$947K 0.1% 229
2020
Q4 		$9.38M Buy
16,100
+5,100
+46% +$2.9M 0.1% 226
2020
Q3 		$5.67M Buy
11,000
+600
+6% +$304K 0.06% 267
2020
Q2 		$4.7M Buy
10,400
+4,400
+73% +$1.94M 0.06% 295
2020
Q1 		$2.1M Buy
6,000
+4,200
+233% +$1.54M 0.03% 376
2019
Q4 		$666K Sell
1,800
-200
-10% -$70.5K 0.01% 849
2019
Q3 		$665K Hold
2,000
– – 0.01% 824
2019
Q2 		$625K Hold
2,000
– – 0.01% 852
2019
Q1 		$611K Buy
2,000
+500
+33% +$135K 0.01% 842
2018
Q4 		$348K Buy
1,500
+100
+7% +$26.8K ﹤0.01% 963
2018
Q3 		$438K Sell
1,400
-2,300
-62% -$714K 0.01% 931
2018
Q2 		$1.07M Buy
3,700
+100
+3% +$27.6K 0.01% 664
2018
Q1 		$900K Buy
3,600
+1,600
+80% +$407K 0.01% 681
2017
Q4 		$477K Buy
+2,000
New +$485K 0.01% 827
2015
Q4 		$790K Buy
5,700
+1,500
+36% +$208K 0.01% 621
2015
Q3 		$564K Hold
4,200
– – 0.01% 673
2015
Q2 		$633K Buy
+4,200
New +$601K 0.01% 669

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Virginia Retirement Systems's BIO Position: Q4 2025 in Review

Virginia Retirement Systems reduced its Bio-Rad Laboratories Class A (BIO) stake by 53% in Q4 2025, selling an estimated $477K and leaving 1,370 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #794.

Virginia Retirement Systems first reported a position in BIO in Q2 2015 and has held it in 27 quarters since. The position peaked at $17.7M in Q1 2022. 396 funds tracked by Wall St. Rank hold BIO as of Q4 2025.

  • Virginia Retirement Systems held 1,370 shares of Bio-Rad Laboratories Class A worth $415K as of Q4 2025.
  • Virginia Retirement Systems sold 1,530 Bio-Rad Laboratories Class A shares in Q4 2025, an estimated $477K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #794 holding.
  • Virginia Retirement Systems first reported a position in Bio-Rad Laboratories Class A in Q2 2015 and has held it in 27 quarters since.
  • Virginia Retirement Systems's Bio-Rad Laboratories Class A position peaked at $17.7M in Q1 2022.
  • 396 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.